Digital The growing use of synthetic data in modern pharma The issue isn't whether synthetic data is useful. It is what question we are asking it to answer.
Market Access Sponsored The pre-commercial case for connecting data before acquiring... For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.
Digital Sponsored Why AI transformation is really about people Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.
Market Access Consolidating data strategy for global success: Insights fro... At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Sales & Marketing Unlocking pharma launch potential: Integrated data strategie... Launch teams need real-time, integrated intelligence to navigate tighter markets, faster timelines, and rising expectations.
Sales & Marketing Sponsored Beyond the grid: Rethinking tracking studies for pharma’s ne... As the healthcare landscape continues to evolve rapidly, the tools used to understand it must keep pace.
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.